Shorted

Micro-X (MX1) Short Interest

Micro-X (ASX:MX1) had 0.02% of shares reported as short positions as of 2 Oct 2026, representing 141,520 shares. Micro-X operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Micro-X logo
MX1

Micro-X

Health Care Equipment & Services

Micro-X designs, develops, and manufactures ultra-lightweight X-ray products using carbon nanotube (CNT) technology. They target the global healthcare and security markets with innovative imaging solutions. Their core technology allows for smaller, lighter, and more efficient X-ray devices compared to traditional methods.

Short position

short percentage0.02%
reported shorts141.5K
shares on issue752.437M

Micro-X (ASX:MX1) has 0.02% of its shares on issue reported as short positions as of 2 Oct 2026, or about 141,520 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 1.49% in August 2023. MX1 is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 40, 2026.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

MX1 intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required
Short interest history & FAQ

MX1 Short Interest History

30-day change
+0.01pp
90-day change
+0.01pp
1-year change
+0.02pp
All-time high
1.49% (August 2023)
All-time low
0.00% (September 2022)

Is MX1 heavily shorted?

Not especially: 0.02% short interest is modest by ASX standards, ranking #563 of 803 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.

How has MX1's short interest changed recently?

Over the past 30 days Micro-X's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.02% of shares on issue.

What is the highest MX1's short interest has been?

Since 2017, Micro-X's short interest peaked at 1.49% in August 2023 and bottomed at 0.00% in September 2022.

Where does this data come from?

All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2017. See our methodology.

MX1 fundamentals

In the year to 30 Jun 2026, Micro-X (ASX:MX1) recorded revenue of A$15.1M and a net loss after tax of A$9.9M. A year earlier it recorded revenue of A$13.1M and a net loss after tax of A$13.9M. Year-on-year growth: revenue +15.6% (FY). Net margin −65.5% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 29 Sep 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Strategy fit

How each stock picker strategy reads MX1 today

PassFailUnknown (data missing, or not meaningful for this company)

  • Zanger Breakout

    WatchScore 10rank 1674 of 1959

    • 1. Explosive growth: fail. Revenue +15.6% YoY (FY ending 2026-06-30); still loss-making on EPS (12 months to 2026-06-30); below the +25% threshold
    • 2. A recognisable base: fail. No tight base: only 5 sessions since the pivot high was first set, under 20; 84.6% deep, deeper than 25%
    • 3. Breakout on heavy volume: fail. No close above the A$0.09 pivot on 1.5x volume in the last 5 sessions; close is -44.0% from the pivot
    • 4. Read the market first: fail. XJO in a downtrend: below its 200-day average
    • 5. Relative strength: pass. Beat the S&P/ASX 200 by 42.5 points over 3 months
    • 6. Liquid enough to trade: fail. A$146k average daily turnover over 20 sessions, below the A$250k floor
  • CAN SLIM

    Not a candidate

    • 1. Earnings growth (C and A): fail. Still loss-making on EPS (12 months to 2026-06-30)
    • 2. Sales growth: fail. Revenue +15.6% YoY (FY ending 2026-06-30); below the +20% threshold
    • 3. New highs (N): fail. 57.5% below the 52-week high, more than 5% away
    • 4. Leader, not laggard (L): fail. 6-month relative strength +0.0 points, below the top-quartile cut-off of +7.7
    • 5. Market direction (M): fail. XJO in a downtrend: below its 200-day average
    • 6. Supply and demand (S): fail. A$146k average daily turnover over 20 sessions, below the A$250k floor
  • Minervini Trend Template

    WatchScore 20rank 904 of 1789

    • 1. Above rising averages: fail. Close A$0.05, 150-day A$0.04, 200-day A$0.05: 150-day is not above the 200-day
    • 2. 200-day trending up: fail. 200-day average A$0.05 vs A$0.06 a month ago (-9.2%): not rising
    • 3. Well off the low: pass. Close A$0.05 is 264.3% above the 52-week low of A$0.01
    • 4. Near the high: fail. 57.5% below the 52-week high, more than 25% away
    • 5. Relative strength: fail. 6-month relative strength +0.0 points, below the top-quartile cut-off of +7.7
    • 6. Above the 50-day: pass. Close A$0.05 vs 50-day average A$0.03 (+66.9%)
    • 7. Liquid enough to trade: fail. A$146k average daily turnover over 20 sessions, below the A$250k floor
  • Crowded-Short Breakout

    WatchScore 15rank 661 of 1533

    • 1. Crowded short: fail. 0.02% of shares on issue reported short, under 5%
    • 2. Days to cover: fail. 0.1 days of average volume to cover, under 5
    • 3. Breakout on heavy volume: fail. No close above the A$0.09 pivot on 1.5x volume in the last 5 sessions; close is -44.0% from the pivot
    • 4. Market direction: fail. XJO in a downtrend: below its 200-day average
    • 5. Liquid enough to trade: fail. A$146k average daily turnover over 20 sessions, below the A$250k floor
    • 6. Relative strength: pass. Beat the S&P/ASX 200 by 42.5 points over 3 months
  • Quality compounders

    WatchScore 9rank 1420 of 1687

    • 1. High return on equity: unknown. Return on equity cannot be measured: it needs net profit, equity at both ends of the year and, outside banks, insurers and other financials, equity of at least 10% of total assets
    • 2. Healthy profit margin: fail. Net margin -65.5% (FY ending 2026-06-30), below the 10% threshold
    • 3. Profit that turns into cash: fail. Net profit is zero or negative, so there is no profit to convert to cash (FY ending 2026-06-30)
    • 4. Little debt: unknown. Net debt cannot be measured: no aligned balance sheet with debt and cash
    • 5. Liquid enough to trade: fail. A$146k average daily turnover over 20 sessions, below the A$250k floor
    • 6. Long-term uptrend: fail. Close A$0.05 vs 200-day average A$0.05 (-1.5%): not above the 200-day average
    • 7. Revenue not shrinking: pass. Revenue +15.6% YoY (FY ending 2026-06-30)

Prices to 7 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial advice

Company

AI-generated research profile of Micro-X

X-ray Technology
Medical Imaging
Security Imaging
Carbon Nanotubes
ASX

Latest MX1 news

All news

About

website

micro-x.com

address

A14, 6 MAB Eastern Promernade, Tonsley, CLOVELLY PARK, SA, AUSTRALIA, 5042

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

4DX
11.0%
4DX
AYA
8.3%
AYA
PNV
7.3%
PNV
NAN
6.8%
NAN
RHC
5.5%
RHC
View all stocks in this industry

Be the first to discuss MX1

Start a research thread or post the first pulse update

Open community